NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05/06/2026
Back to search
Official data from USPTO
GOLD STANDARD STEM CELL THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GOLD STANDARD STEM CELL THERAPY
ST13
US500000088343971Class
44
Filing
88343971
Registration
5969456
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
05/07/2026
Trademark type
Word
Nice classes
44
Filing date
03/18/2019
Registration date
01/21/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2026
Last transaction
05/07/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
First use anywhere
07/20/2017
First use in commerce
07/20/2017
Drawing code
4
Owner type
03
Owner location
Huntsville, AL, US
Examiner
NELMAN, JESSE M
Current location
Historical data usage
Holders and representatives
Holders
Regenesis, Inc.
Representatives
Jeremy A. Smith LANIER FORD SHAVER & PAYNE P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical servicesstem cell therapy and platelet-rich plasma therapy; Regenerative medical and aesthetic servicesstem cell therapy and platelet-rich plasma therapy
Publications
History of USPTO decisions and trademark events.
25 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/06/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/04/2026
ES8R
TEAS SECTION 8 RECEIVED
12/29/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/21/2025
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/21/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/17/2019
ALIE
ASSIGNED TO LIE
12/09/2019
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
12/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/02/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/16/2019
GNFR
FINAL REFUSAL E-MAILED
06/16/2019
CNFR
FINAL REFUSAL WRITTEN
06/16/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/31/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/30/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/30/2019
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/30/2019
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/30/2019
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
05/30/2019
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
05/30/2019
DOCK
ASSIGNED TO EXAMINER
05/29/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/04/2019
NWAP
NEW APPLICATION ENTERED
03/21/2019
Continuous trademark protection
Get notified about every new filing that threatens GOLD STANDARD STEM CELL THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.